National Research (NASDAQ:NRC) Hits New 1-Year Low at $33.01

National Research Co. (NASDAQ:NRC)’s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $33.01 and last traded at $33.01, with a volume of 1052 shares traded. The stock had previously closed at $33.32.

Analysts Set New Price Targets

Separately, TheStreet cut shares of National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Price Performance

The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67. The stock’s fifty day moving average is $38.76 and its 200-day moving average is $40.25. The stock has a market capitalization of $799.45 million, a P/E ratio of 26.66 and a beta of 0.42.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The company had revenue of $38.00 million during the quarter.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Friday, March 29th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Wednesday, March 27th. National Research’s dividend payout ratio (DPR) is 38.40%.

Institutional Investors Weigh In On National Research

Hedge funds have recently bought and sold shares of the company. Qube Research & Technologies Ltd bought a new stake in National Research during the third quarter valued at about $45,000. Lazard Asset Management LLC bought a new stake in National Research during the first quarter valued at about $49,000. Gladius Capital Management LP raised its position in shares of National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after buying an additional 496 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of National Research by 675.3% during the first quarter. Tower Research Capital LLC TRC now owns 1,349 shares of the company’s stock valued at $59,000 after buying an additional 1,175 shares during the last quarter. Finally, State of Wyoming raised its position in shares of National Research by 154.0% during the second quarter. State of Wyoming now owns 1,722 shares of the company’s stock valued at $75,000 after buying an additional 1,044 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.